Integrated Diagnostics for Prostate Cancer

Projektinformationen

ID-PROSTATE

ID Finanzhilfevereinbarung: 961205

DOI

10.3030/961205

Das Projekt endete am 18 Februar 2022

EK-Unterschriftsdatum 14 Juli 2020

Startdatum 1 Juli 2020

Enddatum 30 Juni 2022

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten

€ 3 000 531,25

EU-Beitrag

€ 2 100 371,88

Koordiniert durch

QUANTIB BV
Netherlands

Periodic Reporting for period 2 - ID-PROSTATE (Integrated Diagnostics for Prostate Cancer)

Berichtszeitraum: 2021-07-01 bis 2022-06-30

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

Prostate cancer is the most common type of cancer in men and their second leading cause of death; however, it is highly treatable in the early stages. Recent studies and clinical trials have demonstrated the efficiency of prostate MRI in early diagnosis, with 5 times less missed cancer cases and 25 % fewer biopsies. Care standards now recommend MRI prior to every biopsy, leading to an increased demand for prostate MRI scans. Conventional radiology reading capacity cannot keep pace with the demand. Quantib BV (Netherlands) developed an AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists. The current EU-funded ID-PROSTATE project allows further improvement and acceleration focusing on product commercialization.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

An initial version of Quantib Prostate was completed and certified for clinical use in both the United States (FDA clearance) as well as within the EU (CE-certification). This initial version is in use across a network of sites leading to workflow / UX improvements being released rapidly. In addition this initial version has provided critical insight into the needs for the expanded version featuring additional AI-components which has now also been submitted for review to the FDA.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

We expect the expanded version will deliver the ability for clinicians to report on prostate MR at speed beyond the current state-of-the-art. This will impact the adoption and high-quality and cost-effective use of MRI in early diagnosis of prostate cancer and will thus impact men across Europe and the United States.

banner-logo-psa-not-filled.png